Use of SPECT-CT for Comparison of Dosimetry Methods in PSMA-targeted Radioligand Therapy (SPECTacular Study)
NCT05823402
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Metastatic Castration-resistant Prostate Cancer
Interventions
DIAGNOSTIC_TEST:
SPECT/CT
Sponsor
BAMF Health